Loading

LEGISLATION

  • by Carly Wolf, NORML Political Associate August 17, 2018

    Welcome to the latest edition of NORML’s Weekly Legislative Roundup!

    At the state level, North Dakota’s secretary of state’s office determined that activists collected enough signatures to qualify a far-reaching marijuana legalization initiative for the November ballot. The campaign behind one Missouri medical cannabis initiative filed lawsuits seeking to block two other measures from appearing on the ballot.The measure sets no limits on possession amounts or plant counts.

    New Jersey’s Senate president said lawmakers are close to agreeing on a final draft of a marijuana legalization bill and that a vote could happen next month. The Oklahoma legislature’s medical marijuana working group heard concerns from law enforcement at a meeting and Utah lawmakers met in an interim committee to discuss medical cannabis issues.

    At a more local level, activists in Nelsonville, Ohio are submitting new petitions for a proposed marijuana depenalization ballot measure after errors were identified with their first attempt and activists in Fremont, Ohio qualified a marijuana depenalization measure for the November ballot. The Sacramento, California City Council approved an equity plan intended to let people impacted by the war on drugs participate in the legal cannabis industry.

    Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

    Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

    Your Highness,
    Carly

    Priority Alerts

    Federal

    End Cannabis Criminalization: Senate Minority Leader Chuck Schumer introduced legislation, the Marijuana Freedom and Opportunity Act, to remove marijuana from the Controlled Substances Act and to provide funding for the expungement of criminal records for those with past marijuana convictions.

    Click here to e-mail your senators and urge them to support this important legislation

    Commonwealth of the Northern Mariana Islands

    House Bill 20-178 seeks to legalize, tax, and regulate cannabis in the US territory of the Commonwealth of the Northern Mariana Islands, and would also allow medical marijuana and industrial hemp. HB 20-178 was re-introduced by Rep. Joseph P. Deleon Guerrero (R-Saipan) after amending SB 20-62 by Sen. Sixto K. Igisomar (R-Saipan) since the latter’s bill had revenue-generating sections that led to procedural issues. The bill was already approved by the House earlier this month.

    Update: The bill is expected to unanimously pass and could be on Gov. Ralph DLG Torres’ desk before the year ends.

    CNMI resident? Click here to email your elected officials in support of legalization

    California

    Assembly Bill 1793 seeks to allow automatic expungement or reduction of a prior cannabis conviction for an act that is not a crime as of January 1, 2017, or for a crime that as of that date subject to a lesser sentence. The bill was already approved by the Assembly earlier this year.

    Update: AB 1793 was heard by the Senate Appropriations Committee again on 8/16, and approved by the committee with a 5-2 vote.

    CA resident? Click here to email your elected officials in support of expungement

    Senate Bill 829 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. The bill was already approved by the Senate earlier this year.

    Update: SB 829 was approved by the Assembly Appropriations Committee with a 12-0 vote on 8/16.

    CA resident? Click here to email your elected officials in support of helping needy patients

    Senate Bill 930 seeks to assist financial institutions in safely conducting transactions with licensed cannabis businesses.

    Update: SB 930 was heard by the Assembly Appropriations Committee on 8/16, and then tabled by the committee, killing the bill for this year.

    That’s all for this week!

  • by NORML August 8, 2018

    Today, Congressman Charlie Crist held a press conference to announce the introduction of the Fairness in Federal Drug Testing Under State Laws Act, HR 6589.

    The bipartisan bill would explicitly bar federal agencies from discriminating against workers solely because of their status as a cannabis consumer, or due to testing positive for marijuana use on a workplace drug test.

    Send a message to your Representative in support of this bill now!

    “Medical marijuana is an issue of compassion, and in the veterans’ community, access is even more important as more and more veterans are turning to cannabis to address chronic pain and PTSD. At the same time, the federal government is the largest employer of veterans; however, private cannabis use even in states that have legalized medical marijuana is prohibited in these positions,” said Congressman Charlie Crist (D-FL). “Our bipartisan bill would protect federal employment for those in compliance with their state’s cannabis laws. Because our veterans shouldn’t have to choose between treatment options or job opportunities.”

    “The time for the federal government to end the practice of arbitrarily discriminating against current and potential workers for marijuana consumption is now,” said NORML Political Director Justin Strekal. “With 47 states having reformed their cannabis laws to be in direct conflict with the federal Controlled Substances Act, individuals acting in compliance with state law should not be denied the opportunity to serve their country as public servants.”

    Enacted in 1986, the Federal Drug-Free Workplace Program made it a condition for employment that all civilian employees at executive branch agencies be prohibited from using federally illegal substances on or off duty. Medical marijuana is currently legal in 31 states, D.C., Puerto Rico, and Guam, and 46 states have some form of medical marijuana law; however, it remains illegal under federal law. Therefore, federal employees can be denied employment or terminated due to testing positive for marijuana metabolites, even if their use is in compliance with state law. This conflict between state and federal laws limits treatment options and federal employment opportunities, particularly impacting veterans who comprise approximately one-third of the federal workforce and whose medical cannabis use to treat chronic pain and PTSD has been found to be double the rate of the general public. A recent American Legion poll found that one in five veterans use marijuana to alleviate a medical condition.

    Changes in the legal status of marijuana at the state level have not negatively impacted workplace safety. In fact, a pair of studies from 2016 find that the legalization of medical marijuana access is associated with greater workforce participation and with fewer workplace absences. Most recently, the National Academies of Sciences just-released marijuana and health report found “insufficient evidence” to support an association between cannabis use and occupational accidents or injuries.

    In 2018, legislative efforts to reform employment laws were either attempted or successful in California, Florida, New Jersey, and Wisconsin, among others.

    Send a message to your Congressperson now and urge them to cosponsor the bill!

    Bill Overview:

    •   The Fairness in Federal Drug Testing Under State Laws Act prohibits marijuana metabolite testing from being used as the sole factor to deny or terminate federal employment for civilian positions at executive branch agencies if the individual is in compliance with the marijuana laws in their state of residence.
    •   The bill only extends to an individual’s past, private use of cannabis, and does not prohibit probable cause testing if an individual is believed to be impaired at work.
    •   The bill does not apply to individuals occupying or seeking a position requiring a top-secret clearance.
  • by Carly Wolf, NORML Political Associate August 3, 2018

    Welcome to the latest edition of NORML’s Weekly Legislative Roundup!Legalize marijuana

    Congressman Charlie Crist (D-FL) and Congressman Drew Ferguson (R-GA) filed a new bill in the US House of Representatives this week to shield federal employees from being fired for marijuana use that is legal in the state in which they live.

    The Oklahoma Board of Health reversed course this week and revoked their previous set of proposed rules that went against the intent of SQ 788, which voters approved in the June special election. This reversal comes shortly after the state’s Attorney General warned health officials that they “acted in excess of their statutory authority” when they amended State Question 788. These new rules now go to Governor Fallin’s desk, she has 45 days to approve or reject them. As a reminder, the proposed rules remove the ban on the retail sale of herbal cannabis, eliminate the requirement that dispensaries hire state-licensed pharmacists, and no longer mandate that women of childbearing age undergo a pregnancy test prior to receiving a medical cannabis recommendation.

    Missouri’s secretary of state certified that three separate medical cannabis initiatives have enough signatures to appear on the November ballot. The Missouri Constitution specifies that if conflicting initiative measures appear on the same ballot, the one which receives the most votes will prevail. It is likely that all three of these measures will have the support of a majority of the voters. Two are constitutional amendments and the third is a statutory initiative.

    New York Gov. Andrew Cuomo (D) formed a working group to draft marijuana legalization legislation for the legislature to consider in 2019. And Hawaii regulators convened a working group to address employment issues for medical cannabis patients as well as edibles manufacturing.

    Also at the state level, about half of the medical cannabis dispensaries in Pennsylvania began selling medical cannabis in herbal form to registered patients, and the other half are anticipated to do the same this coming week. And Rhode Island medical cannabis dispensaries began serving out-of-state patients.

    Additionally, Illinois Gov. Bruce Rauner (R) signed a bill allowing medical cannabis in schools. Also, autism and obstructive sleep apnea became Minnesota medical cannabis qualifying conditions on Wednesday.

    At a more local level, Manhattan’s district attorney announced that his office will no longer prosecute marijuana use or possession.

    The Racine, Wisconsin City Council is considering placing a marijuana legalization advisory question on the November ballot, and similarly, the Eau Claire County, Wisconsin Administration Committee voted to advance consideration of marijuana advisory ballot questions. The Oregon, Ohio City Council placed a marijuana depenalization measure on the November ballot, but a proposed Nelsonville, Ohio marijuana decriminalization measure did not qualify for the November ballot.

    Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

    Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

    Your Highness,
    Carly

    Priority Alerts

    Federal

    End Cannabis Criminalization: Senate Minority Leader Chuck Schumer introduced legislation, the Marijuana Freedom and Opportunity Act, to remove marijuana from the Controlled Substances Act and to provide funding for the expungement of criminal records for those with past marijuana convictions.

    Click here to e-mail your senators and urge them to support this important legislation

    Commonwealth of the Northern Mariana Islands

    Senate Bill 20-62 seeks to legalize the personal use and cultivation of small amounts of marijuana for adults age 21 or older, and establish a licensing scheme for its commercial production and retail sale. The tax revenue would be used to fund the implementation of the program and other government services.

    Update: The House of Representatives sent SB 20-62 back to committee on 8/1, but will soon introduce its own version of the legislation that should solve procedural issues around it being a revenue generating measure.

    CNMI resident? Click here to email your elected officials in support of legalization and regulation

    California

    Expungement

    Assembly Bill 1793 seeks “to allow automatic expungement or reduction of a prior cannabis conviction for an act that is not a crime as of January 1, 2017, or for a crime that as of that date subject to a lesser sentence.

    Update: AB 1793 will be heard by the Senate Appropriations Committee on 8/6 at 10am in the John L. Burton Hearing Room.

    CA resident? Click here to email your elected officials in support of expungement

    Banking

    Senate Bill 930 seeks to assist financial institutions in safely conducting transactions with licensed cannabis businesses.

    Update: SB 9030 will be heard in the Assembly Appropriations Committee on 8/8 at 9am in the State Capitol, Room 4202.

    CA resident? Click here to email your elected officials in support of banking access for cannabis businesses

    That’s all the legislative updates for this week!

  • by Carly Wolf, NORML Political Associate July 27, 2018

    Welcome to the latest edition of NORML’s Weekly Legislative Roundup!

    We’ve got a new piece of legislation at the federal level. In conjunction with NORML’s 2018 Lobby Day, Reps. Tulsi Gabbard (D-HI-02) and Carlos Curbelo (R-FL-26) introduced The Marijuana Data Collection Act. The act calls upon the National Academy of Sciences to collect and synthesize relevant data and to generate a formal report to Congress quantifying the impact of statewide marijuana legalization on matters specific to public health, safety, the economy, and criminal justice, among other issues. The report would also outline best practices for state-led data collection, as well as recommendations to overcome any barriers preventing data collection and gaps in data. Watch the press conference.

    Earlier in the week, the US House Rules Committee led by prohibitionist Representative Pete Sessions (R-TX) blocked two amendments related to marijuana from receiving consideration by the full House, thus ending their consideration and silencing the ability for the lower chamber to offer protections from the DOJ when it comes to cannabis. The amendments included allowing the District of Columbia to implement adult-use sales program, originally passed by voters in 2014, and protections for banks to provide services to marijuana businesses.

    At the state level, New Jersey’s state Attorney General has called on county and municipal prosecutors to suspend all marijuana-related prosecutions until early September. Also, a fiscal report issued by Pennsylvania’s Auditor General estimates that taxing Pennsylvania’s existing retail cannabis market would yield $581 million in new annual revenue. The report estimates that just under 800,000 Pennsylvanians are currently using cannabis. On that note, Pennsylvania dispensaries are set to begin selling medical cannabis in flower form this week.

    Oklahoma’s secretary of state said that proposed marijuana legalization and medical cannabis expansion initiatives are unlikely to appear on the November ballot even if they do collect enough signatures. But regulators will meet on August 1 to revisit widely criticized restrictive medical cannabis rules. The newly proposed changes eliminate several restrictive amendments enacted by the Department earlier this month, including removing the ban on the retail sale of herbal cannabis, eliminating the requirement that dispensaries hire state-licensed pharmacists, and no longer mandating that women of childbearing age undergo a pregnancy test prior to receiving a medical cannabis recommendation. No such restrictions initially appeared in the voter approved State Question 788. Meanwhile, it seems unlikely that lawmakers will go into special session to deal with medical marijuana implementation.

    At a more local level, the Marathon County, Wisconsin Board voted to place a medical cannabis advisory question on the November ballot. The Ostego County, Michigan Board of Commissioners voted to oppose the state’s marijuana legalization ballot measure, and the Grand Rapids, Michigan City Commission voted to allow medical cannabis businesses in its jurisdiction.

    Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

    Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

    Your Highness,
    Carly

    Priority Alerts

    Federal

    End Cannabis Criminalization: Senate Minority Leader Chuck Schumer introduced legislation, the Marijuana Freedom and Opportunity Act, to remove marijuana from the Controlled Substances Act and to provide funding for the expungement of criminal records for those with past marijuana convictions.

    Click here to e-mail your senators and urge them to support this important legislation

    California

    Assembly Bill 1793 seeks “to allow automatic expungement or reduction of a prior cannabis conviction for an act that is not a crime as of January 1, 2017, or for a crime that as of that date subject to a lesser sentence.

    Update: AB 1793 will be heard by the Senate Appropriations Committee on 8/6 at 10am in the John L. Burton Hearing Room.

    CA resident? Click here to email your elected officials in support of expungement

    Kentucky

    House Bill 166 seeks to allow for the physician-authorized use of marijuana for patients with specific debilitating medical conditions.

    Update: Rep. Jason Nemes, one of the bill’s cosponsors, announced on Twitter that the bill will be heard in the House Judiciary Committee on 9/7.

    KY resident? Click here to email your elected officials in support of medical cannabis access

    That’s all for this week!

  • by NORML July 25, 2018

    Reps. Tulsi Gabbard (HI-02) and Carlos Curbelo (FL-26) led a group of bipartisan lawmakers in introducing The Marijuana Data Collection Act. The act calls upon the National Academy of Sciences (NAS) to collect and synthesize relevant data and to generate a formal report to Congress quantifying the impact of statewide marijuana legalization on matters specific to public health, safety, the economy, and criminal justice, among other issues.

    Numerous published peer-reviewed studies have assessed the impact of state-regulated marijuana legalization on these issues, but despite the publication of these reports, a lack of consensus and acceptance of this data continue, particularly amongst members of Congress and the Department of Justice.

    Speaking about the new bill on the House floor, Congresswoman Gabbard stated, “For decades, bad data and misinformation have fueled the failed war on drugs that’s wasted billions of taxpayer dollars, incarcerating Americans for nonviolent marijuana charges. Our outdated marijuana policies have turned  everyday Americans into criminals, strained our criminal justice system, cost taxpayers tremendously and torn families apart.”

    You can watch the press conference announcing the legislation featuring the bill’s lead GOP cosponsor Rep. Carlos Curbelo (R-FL), lead Democrat cosponsor Rep. Tulsi Gabbard (D-HI), we well as former U.S. Attorneys Barry Grissom (KS) and Bill Nettles (SC) below:

    Commenting on the legislation, NORML Political Director Justin Strekal said, “This report will ensure that federal discussions and policies specific to this issue are based upon the best and most reliable evidence available. The data collected and compiled by the National Academy of Sciences will help to guide future marijuana legislation at federal, state, and local levels. This is not a marijuana bill, it is an information bill. No member of Congress can intellectually justify opposition to this legislation. Our public policy needs to be based on sound data and science, not gut feelings or fear-mongering. Approving the Marijuana Data Collection Act would provide legislators with reliable and fact-based information to help them decide what direction is most beneficial to society when it comes to marijuana policy.”

    This bill requires data collection and study with regard to the impact of state-regulated marijuana legalization on public health, safety, the economy, and criminal justice, among other issues. Specifically, this bill requires the Secretary of HHS to coordinate with the DOJ, DOL, and States (to the greatest extent possible) and direct the National Academy of Sciences (NAS) to publish a biannual study on the health, safety, and economic effects of state legalized marijuana programs. The report would also outline best practices for state-led data collection, as well as recommendations to overcome any barriers preventing data collection and gaps in data.

    Thirty-one states, Washington, DC and the US territories of Guam and Puerto Rico have enacted legislation specific to the physician-authorized use of cannabis, while an estimated 63 million Americans now reside in jurisdictions where anyone over the age of 21 may possess cannabis legally. Voters overwhelmingly support these policy changes. According to a 2018 CAP poll, 68 percent of Americans support full marijuana legalization and according to Quinnipiac University, 71 percent believe that states, not the federal government, should set marijuana policy.

    To date, these statewide regulatory programs are operating largely as voters and politicians intended. The enactment of these policies have not negatively impacted workplace safetycrime ratestraffic safety, or youth use patterns. They have stimulated economic development and created hundreds of millions of dollars in new tax revenue. Specifically, a 2017 report estimates that 123,000 Americans are now working full-time in the cannabis industry. Tax revenues from states like Colorado, Oregon, and Washington now exceed initial projections. Further, numerous studies have identified an association between cannabis access and lower rates of opioid use, abusehospitalizations, and mortality.

    CLICK HERE TO QUICKLY AND EASILY WRITE YOUR REPRESENTATIVE IN FAVOR OF THIS IMPORTANT LEGISLATION.

Page 3 of 11312345...102030...Last »